Full Press Release Details
TORONTO, ONTARIO and CAMBRIDGE, MA , Sept. 21, 2017 (GLOBE NEWSWIRE) -- ERN UK
PMN
ProMIS Neurosciences Independent Director Anthony J. Giovinazzo Recognized with Inaugural Bloom Burton Award for Innovation in Canadian Healthcare
Key Takeaway: TORONTO, ONTARIO and CAMBRIDGE, MA , Sept. 21, 2017 (GLOBE NEWSWIRE) -- ERN UK
BiopharmaWatch Analysis
From our catalyst data and publicly available data · not financial adviceBest trade, last catalyst
+98%
120-day peak, hindsight
Typical move
16.6%
average across 4 past catalysts
Cash runway
~15 mo
Low dilution risk
Lead asset
PMN310
Phase 1 · Healthy Participants